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a b s t r a c t 
Inﬂammation affects the aortic wall through complex pathways that alter its biomechanical structure and cellular composition. Inﬂammatory processes 
that predominantly affect the intima cause occlusive disease whereas medial inﬂammation and degeneration cause aneurysm formation. 
Aortic inﬂammatory pathways share common metabolic features that can be localized by smart contrast agents and radiolabelled positron emission 
tomography (PET) tracers. 18 F-Fluorodeoxyglucose ( 18 F-FDG) is a non-speciﬁc marker of metabolism and has been widely used to study aortic inﬂammation 
in various diseased aortic states. Although useful in detecting disease, 18 F-FDG has yet to demonstrate a reliable link between vessel wall disease and 
clinical progression. 
18 F-Sodium ﬂuoride ( 18 F-NaF) is a promising biological tracer that detects microcalciﬁcation related to active disease and cellular necrosis within the 
vessel wall. 18 F-NaF shows a high aﬃnity to bind to diseased arterial tissue irrespective of the underlying inﬂammatory process. In abdominal aortic 
aneurysms, 18 F-NaF PET/CT predicts increased rates of growth and important clinical end-points, such as rupture or the requirement for repair. 
Much work remains to be done to bridge the gap between detecting aortic inﬂammation in at-risk individuals and predicting adverse clinical events. 
Novel radiotracers may hold the key to improve our understanding of vessel wall biology and how this relates to patients. Combined with established 
clinical and morphological assessment techniques, PET imaging promises to improve disease detection and clinical risk stratiﬁcation. 
© 2018 Published by Elsevier Inc. 
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mIntroduction 
Aortic diseases have varying clinical presentations and equally
diverse underlying mechanisms. However, inﬂammation plays an
important role in most major aortic pathologies, leading to
degradation of the vessel wall and potentially vessel occlusion,
aneurysm formation or dissection. Each represents a potentially
catastrophic cause of morbidity and mortality for patients that fre-
quently occurs without clinical warning. 
The ability to monitor aortic inﬂammation accurately and non-
invasively would therefore represent a major advance. Serum
markers are non-speciﬁc to aortic inﬂammation and are unable to
identify focal areas of disease or injury. Furthermore, whilst mod-
ern imaging techniques may detect aortic morphology and periaor-
tic changes with great anatomical detail, they are unable to inform
on the biological activity within the aortic wall itself. Metabolic
imaging has the potential to meet this important unmet clinical
need. Imaging probes can be used to identify inﬂammation di-
rectly or closely associated processes, allowing disease activity to
be measured with imaging techniques such as positron emission
tomography. 
A combination of morphological analysis and molecular imag-
ing presents an opportunity to detect and characterize aortic dis-
ease better. In this review, we will explore emerging molecu-
lar techniques in this ﬁeld, describe the established evidence of
their utility and discuss their potential to improve risk stratiﬁ-
cation and enable targeted therapy to improve patient care and
outcomes. 
Pathophysiology of aortic wall inﬂammation 
Aortic inﬂammation occurs in response to tissue injury and
cellular stress. Repair and remodelling pathways trigger pro-
inﬂammatory mechanisms that lead to further tissue damage. We
focus on the inﬂammatory processes and key pathological mecha-
nisms that affect the aorta. These include atherosclerosis, aneurys-
mal formation and autoimmune aortitis. 
Atherosclerotic disease is an abnormal immune-mediated re-
sponse to modiﬁed subendothelial lipoproteins. The result is
atheroma formation within the intima of large and medium-sized
arteries, including the aorta. Vulnerable plaques consist of a lipid-
rich necrotic core surrounded by activated immune cells. There is a
loss of extracellular matrix proteoglycans and collagen, along with
the deposition of calcium. A ﬁbrous cap attempts to contain this
necrotic content and is composed of varying quantities of migra-
tory smooth muscle cells, endothelial cells and calciﬁcation. Plaque
rupture occurs when the ﬁbrous cap fractures, instigating an acute
inﬂammatory cascade and resulting in rapid thrombus formation.
In the aorta, distal thromboembolism causes visceral or limb is-
chemia. Alternatively plaque rupture can be sub-clinical, resulting
in plaque healing and growth. Progressive disease causes luminal
stenosis, restricting ﬂow to distal organs and potentially causing
ischemic symptoms. 
Aortic aneurysm formation includes an inﬂammatory mediated
process but is distinct from atherosclerosis because it is charac-
terized by media atrophy rather than intimal proliferation ( Fig. 1 )
[1,2] . Consequent thinning, weakening and stiffening of the aortic
wall leaves it vulnerable to dilatation and rupture. 
Autoimmune aortitis, such as Takayasu and giant cell dis-
ease, is far less common than atherosclerosis and aortic aneurysm
formation. Large vessel vasculitis is characterized by inﬂamma-
tory inﬁltrates within the aortic adventitia and vasa-vasorum. The
chronic inﬂammatory course of vasculitis leads to progressive in-
timal wall thickening that causes vessel stenosis or occlusion
[3] . Please cite this article as: M.B.J. Syed, A.J. Fletcher and M.R. Dweck e
Medicine, https://doi.org/10.1016/j.tcm.2018.12.003 mmune-mediated inﬂammation 
In atherosclerosis, macrophage and smooth muscles cells en-
ocytose modiﬁed-lipoproteins to become foam cells ( Fig. 2 ).
acrophage foam cells in the intima produce pro-inﬂammatory
ytokines such as tumor necrosis factor- γ , interleukin (IL)-1 β , IL-
 and chemokine CCL2: stimuli that recruit macrophages, mast
ells, platelets, T-lymphocytes and dendritic cells. All of these con-
ribute to ongoing inﬂammation [4] . Local antigen presentation ac-
ivates an adaptive immune response that includes cytotoxic CD8 +
-cells. These are implicated in smooth muscle and macrophage
ell death [5] . T-helper cells (CD4 + ), speciﬁcally Th1 subcategories,
ontribute to overall inﬂammation by producing cytokines includ-
ng interferon- γ and tumor necrosis factor [6] . 
In contrast, inﬂammation in aortic aneurysms primarily affects
he media and adventitia. The chief immune mediator in aortic
neurysm formation appears to be CD4 + T-lymphocytes through
he production of interferon- γ [7] . Whereas Th1 cells contribute
o atherosclerosis, Th2 cells are strongly implicated in aneurysmal
isease. These produce IL-4, IL-5 and IL-13, which stimulate natural
iller cells to produce matrix metalloproteinases (MMP) and cause
edial smooth muscle atrophy [2] . Th17 are common to both,
therosclerotic and aneurysmal disease. They promote macrophage
ctivation by releasing tumor necrosis factor- α, IL-6 and IL-1. These
ytokines have downstream effects that promote MMP-9 expres-
ion and smooth muscle loss [8] . 
Similar to aortic aneurysm formation, Takayasu aortitis is an
daptive immune response with inﬁltration including Th1 and
h17 cell subtypes. The initial trigger is unknown, although
ycobacterial-related heat shock protein is speculated [9] . Unlike
ortic aneurysm formation, inﬂammatory lesions in Takayasu aor-
itis are largely formed in the adventitia via the vasa-vasorum [9] .
edial inﬂammation driven by macrophages expressing vascular
ndothelial growth factor and platelet-derived growth factor con-
ribute to neovascularization and smooth muscle proliferation and
igration to the intima – the primary cause of severe intimal
hickening [9] . 
ascular calciﬁcation 
Vascular calciﬁcation is a healing response to inﬂammation and
issue degradation. Detection of the early stages of microcalciﬁca-
ion therefore acts as a surrogate of inﬂamed damaged aortas. By
omparison, detection of the latter stage of macrocalciﬁcation is
ssociated with inﬂammation that is healing or burnt out. 
Vascular calciﬁcation is characterized by the initial deposition
f microscopic calcium- and phosphate-containing hydroxyapatite
rystals. Macrophages produce calcifying matrix vesicles that con-
ribute to intimal microcalciﬁcation in atherosclerosis [10] . Smooth
uscle cells that migrate to the intima also undergo osteoblas-
ic change and encourage intimal microcalciﬁcation [11] . Deposits
f microcalciﬁcation within the media are associated with elastin
reaks in both chronic kidney disease and aneurysmal aortic spec-
mens in patients with connective tissue disorders [12] . 
etecting aortic inﬂammation 
Aortic inﬂammation is progressive and silent. Symptoms do not
ccur until advanced stages of disease and often signal impend-
ng catastrophe. Hence, the early detection of aortic inﬂammation
ould be pivotal to identify and monitor disease as well as direct
arly therapy. In aortitis, biological drugs used to target aortic in-
ammation are potentially toxic. Newer anti-inﬂammatory drugs
re effective but are expensive and there is a need to ensure treat-
ent is directed to the right patient. t al., Imaging aortic wall inﬂammation, Trends in Cardiovascular 
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Fig. 1. Medial degeneration. Histologic images showing grades of medial degeneration. ( A ) Normal aorta. ( B ) Mild medial degeneration characterized by pooling of pro- 
teoglycan between elastic lamellae. ( C ) Moderate medial degeneration with focal loss of elastic lamellae and proteoglycan deposition. ( D ) Severe medial degeneration with 
marked loss of elastic lamellae, SMCs, and extensive proteoglycan deposition. All Movat pentachrome stain [1] . 
Table 1 
The strengths of different aortic imaging modalities. 
Imaging modality 
Duplex ultrasound Computed tomography Magnetic resonance imaging Positron emission tomography 
Aortic morphology + ++ + 
Luminal morphology + ++ ++ 
Aortic wall thickness + + ++ 
Metrics of blood ﬂow ++ + 
Calciﬁcation ++ 
Thrombus characterisation ++ Novel thrombus and ﬁbrin targeting radiotracers 
Glucose metabolism ++ 
18 F-ﬂuorodeoxy-glucose 
Macrophage inﬁltration ++ ++ 
USPIO 18 F-DOTATATE, VCAM-1, 11 C-Choline, 11 C-PK11195 
Microcalciﬁcation ++ 
18 F-Sodium Fluoride 
Vessel wall angiogenesis + + 
Contrast-Enhanced US 18 F-Galacto-RGD 
[ ++ ] – Ideally suited; [ + ] – Detection is possible. 
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t  ssessing aortic diameter and wall thickness 
Aortic remodelling alters the shape of the aorta, which is best
etected with ultrasound, computed tomography (CT) or magnetic
esonance imaging (MRI). These modalities are the cornerstone of
odern aortic imaging in contemporary clinical practice ( Table 1 ). 
Ultrasound is the screening modality of choice for sub-
iaphragmatic aortic disease owing to its reproducible results,
ide availability and relative affordability. Duplex ultrasonogra-
hy can detect the morphology of the abdominal aorta and
ts branches, along with changes in the velocity of blood ﬂow.
ince ultrasound cannot penetrate bony structures, visualizing
he thoracic aorta requires a transesophageal probe. However,
ore detailed techniques are required to distinguish morphologi-
al changes speciﬁc to inﬂammation. Please cite this article as: M.B.J. Syed, A.J. Fletcher and M.R. Dweck e
Medicine, https://doi.org/10.1016/j.tcm.2018.12.003 Catheter angiography outlines the aortic lumen with excep-
ional detail. However, it is invasive and associated with poten-
ial complications including arterial injury, radiation exposure and
ephrotoxicity. Non-invasive imaging techniques are a preferred al-
ernative to catheter angiography because they image the whole
orta with minimal risk of iatrogenic complications. Modern CT
nd MRI have excellent spatial resolution and can accurately de-
ect luminal irregularities. They also obtain images of the vessel
all and associated peri-aortic tissue. MRI has better soft tissue
haracterization than CT and is better at assessing wall thickness
13] . 
CT is well suited to detect established calciﬁed plaque owing to
ts reliance on x-rays for image acquisition. Modern CT scanners
an detect mature plaques and CT texture analysis offers an objec-
ive approach to analyzing individual lesions. The total burden oft al., Imaging aortic wall inﬂammation, Trends in Cardiovascular 
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Fig. 2. Summary of the principle underlying inﬂammatory mechanisms and subsequent clinical manifestations affecting atherosclerosis, aortic aneurysm formation and 
aortitis. eNOS = endothelial nitric oxide synthase, INF = interferon, IL = Interleukin, LDL = low density lipoprotein, MMP = Matrix metalloproteinase, NK = natural killer, NF- 
KB = nuclear factor kappa-light-chain-enhancer of activated B cells, ox = oxidized, ROS = reactive oxygen species, PDGF = platelet derived growth factor, SMC = smooth muscle 
cell, Th = T-helper, TNF = Tumour necrosis factor, VEGF = vascular endothelial growth factor. Images adapted from https://smart.servier.com (Servier Medical Art by Servier) used 
under a creative commons license. 
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avessel calciﬁcation can be quantiﬁed with a calcium score. Calcium
scores are a condensed, yet powerful, metric that provide objectiv-
ity to the heterogenous patterns of calciﬁcation within the aorta.
These scores can be used in risk stratiﬁcation models to predict
disease progression. 
Both, CT and MRI, reliably detect aortic changes when the wall
is thickened as is seen in vasculitis [14] . The inﬂamed artery ap-
pears as a ring of high attenuation on arterial phase CT imaging
within a thickened low-attenuation aortic wall ( Fig. 4 ) [15] . The in-
ﬂamed wall is frequently littered with spotty calciﬁcation and the
calibre of the vessel itself may be increased. These high-risk fea-
tures signal active disease that is congruent over large sections of
the aorta. 
Serum markers of disease activity 
Inﬂammatory mediators produced in diseased aortic wall, such
as interleukins and matrix metalloproteinases, are elevated in the
serum of patients with aortopathy [16] . These likely represent
global vascular inﬂammation and are better suited to assessing
aortitis compared to atherosclerotic or aneurysmal disease [17] . Please cite this article as: M.B.J. Syed, A.J. Fletcher and M.R. Dweck e
Medicine, https://doi.org/10.1016/j.tcm.2018.12.003 Immunoglobulin-G subtype 4 (IgG-4) is increasingly being rec-
gnized as a potent mediator of autoimmune aortitis. Serum
gG-4 upregulates pro-inﬂammatory interleukins and is markedly
ncreased in “inﬂammatory” aneurysms [16] . High IgG-4 concen-
rations are associated with larger aortic sizes [18] and up to a
uarter of patients with IgG-4 related disease progress to develop
neurysms [19] . Serum c-reactive protein and erythrocyte sedi-
entation rates in these patients indicate the burden of global vas-
ular inﬂammation and allows the monitoring of therapy. 
maging biological activity within the aortic wall 
Non-invasive imaging allows inﬂammatory activity to be mea-
ured speciﬁcally within the aorta, thereby overcoming many of
he limitations associated with serum biomarkers. Novel biologi-
al radiotracers detect speciﬁc disease processes and the pattern
f radioactive decay can be detected using positron emission to-
ography (PET), which offers sensitive detection of radiotracers
nd produces a topological map of tracer binding. PET is inherently
ow-resolution. For this reason, it is combined with CT or MRI for
natomical context. t al., Imaging aortic wall inﬂammation, Trends in Cardiovascular 
M.B.J. Syed, A.J. Fletcher and M.R. Dweck et al. / Trends in Cardiovascular Medicine xxx (xxxx) xxx 5 
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Fig. 3. Computed tomography, magnetic resonance imaging and positron emission tomography in a patient with an abdominal aortic aneurysm . Axial view of the 
aneurysm as seen on computed tomography ( A ) shows a sac with thrombus and calciﬁed plaque in the aortic wall. T2-weighted magnetic resonance imaging ( B ) can 
differentiate between the lumen ( ∗), thrombus ( • ) and adjacent structures. T2 ∗ magnetic resonance imaging ( C ) shows high ultrasmall particles of iron oxide uptake (arrow) 
in the wall of the aneurysm. The sagittal computed tomography view ( D ) delineates the morphology of the aneurysm. 18F-Sodium Fluoride uptake ( E ) seen anterior to the 
vertebral body (arrows). Superimposing positron emission tomography signals over the computed tomography images ( F ) conﬁrms high 18F-Sodium Fluoride uptake at the 
aneurysm neck, bifurcation and left common iliac artery (arrows). (For interpretation of the references to colour in the text, the reader is referred to the web version of this 
article.) 
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t  Metal-based “smart contrast agents” used with magnetic reso-
ance imaging can identify inﬂammatory changes within vascular
issue. Targeting vascular biological activity in this way offers more
omplete insight to aortic wall disease compared to conventional
natomical-based imaging used routinely in clinical practice. 
RI sensitive smart contrast agents 
One approach to visualize aortic inﬂammation is to image cel-
ular activity within the aortic wall directly. Ultrasmall superpara-
agnetic particles of iron oxide (USPIO) are sub-nanometre com-
ounds that are engulfed by tissue-resident macrophages. They
ave been used to demonstrate macrophage inﬁltration within the
ortic wall owing to their ability to cause a rapid decline in T2 ∗.
his signal change can be represented on visual colour maps by
btaining pre- and post-USPIO MRI sequences ( Fig. 3 B–C) [20] . The
egree of signal decay quantiﬁes USPIO accumulation and is a sur-
ogate marker of macrophage activity. 
Tropoelastin is a soluble precursor that cross-links elastin.
ts presence signiﬁes elastin regeneration following extracellular
atrix injury. Tropoelastin is not detectable in healthy tissue.
adolinium-based contrast media can target tropoelastin proteins
nd have been validated in animal aortic models and injured my-
cardium [21,22] . The presence of these proteins is associated with
ocal weakening of the arterial wall and correlates with rupture
ites in mouse models of aneurysms. 
8 F-Fluorodeoxyglucose 
18 F-Fluorodeoxyglucose ( 18 F-FDG) is a glucose analogue that
s trapped in cells with increased glycolytic activity, such as in-
amed aortae. Because 18 F-FDG reﬂects global metabolic activ-Please cite this article as: M.B.J. Syed, A.J. Fletcher and M.R. Dweck e
Medicine, https://doi.org/10.1016/j.tcm.2018.12.003 ty, its binding is non-speciﬁc and overlaps between diseased and
ealthy arterial tissues. In low-grade inﬂammatory conditions, such
s atherosclerosis and aneurysm formation, 18 F-FDG PET is less
ble to detect active disease reliably. 
On the other hand, aortitis reﬂects a much more aggressive
orm of vascular inﬂammation affecting both the intima and me-
ia. Marked vessel wall hypertrophy causes arterial stenosis and
an progress to complete occlusion. Morphological imaging is the
asis of diagnosing vascular complications in aortitis and CT is
ighly sensitive in detecting diseased vessels in patients with large
essel vasculitis [23] . However, per-segment analysis of large ves-
els misses up to 40% of individual lesions [24] . 18 F-FDG PET/CT
mproves the detection of aortitis beyond CT alone by detecting
nﬂamed sections that look normal on CT. 18 F-FDG PET is also in-
uenced by glucocorticoid and immunosuppressant therapy, which
an be used to monitor the eﬃcacy of treatment. However, this is
 double-edged sword because late 18 F-FDG PET scans may miss
essel involvement if therapy has started [25] . 
The true sensitivity of 18 F-FDG PET in vasculitis is unknown.
ongitudinal studies report that nearly half of vasculitis patients
ith biopsy proven disease do not exhibit signiﬁcant 18 F-FDG up-
ake and this proportion reduces further with time [26] . Although
8 F-FDG PET/CT may help detect inﬂammatory aortic disease, it is
ot robust enough to be used in isolation. Indeed, biopsy remains
he gold standard for diagnosing large vessel vasculitis. 
ovel inﬂammatory PET radiotracers 
A number of radiotracers have been developed to detect spe-
iﬁc biological processes. Direct leukocyte detection is possible by
argeting CXCR4 receptors expressed on the surface of multiplet al., Imaging aortic wall inﬂammation, Trends in Cardiovascular 
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Fig. 4. Takayasu arteritis involving aorta with skipped segment in a 50-year-old woman. ( A ) Multiplanar reformation image shows wall thickening (arrowheads) of 
ascending thoracic aorta, aortic arch, proximal descending thoracic aorta, and abdominal aorta. No wall thickening of distal descending thoracic aorta is noted. Motion 
artifact (pulsation artifact) was not observed in the thickened segment such as aortic arch and abdominal aorta due to stiffness of involved aorta and was observed in the 
distal descending thoracic aorta (arrows) due to pulsation of the noninvolved segment. ( B ) CT scan at the proximal descending thoracic aorta shows diffuse wall thickening 
and inner low attenuated ring of ascending (arrow) and descending thoracic aorta (arrowhead). ( C ) CT scan at the distal descending thoracic aorta (arrow) shows no wall 
thickening of aorta. ( D ) CT scan at the abdominal aorta shows diffuse wall thickening and inner low attenuated ring of abdominal aorta (arrow) [15] . 
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vtypes of inﬂammatory cells. Aneurysmal aortic tissue has upreg-
ulated CXCR4 receptors within its aortic wall and animal studies
show that 68 Ga-Pentixafor binds to CXCR4 receptors which localize
to areas of increased aortic wall disease [27] . 
Whereas CXCR4 is expressed by a range of pro-inﬂammatory
leukocytes, it is also possible to target speciﬁc cell lines. For in-
stance, the translocator proteins (TSPO) are 18-kDa glycoproteins
expressed on the mitochondria of activated macrophages in much
larger quantities than other cells [28] . The TSPO ligands can be
radiolabelled and have been tested in human atherosclerotic tis-
sue, where they accurately identify culprit lesions and macrophage
inﬁltration. Aortic studies also show marked uptake of TSPO ra-
diotracers in vasculitis [28] . However, these ﬁndings have not
translated to detect low-grade inﬂammation in aortic aneurysms
[29] . 
Somtatostatin receptor subtype 2 (SST2) receptors are highly
speciﬁc to activated macrophages. Variations in SST2 analogues
combine a DOTA- or NOTA- cage with a 68 Ga or 64 Cu radioiso-
tope attached to a -TATE or -NOC somtatostatin ligand. 68 Ga-
DOTATATE ([ 68 Gallium-DOTA0-Tyr 3 ]octreotate) is the most studied
of these and binds preferentially to atherosclerotic plaques with
high macrophage inﬁltration [30] . 
Degraded aortic tissue exhibits abnormal angiogenesis and is
present in abundance at sites of aortic rupture [31] . 18 F-Galacto-
RGD binds to αv β3 receptors that stimulate angiogenesis, typically
in hypoxic environments [32] . This experimental agent has been
validated in carotid and coronary atherosclerotic plaque, where it
adheres strongly to lesions with a rich network of vasa vasorum. Please cite this article as: M.B.J. Syed, A.J. Fletcher and M.R. Dweck e
Medicine, https://doi.org/10.1016/j.tcm.2018.12.003 8 F-Sodium Fluoride 
Detecting microcalciﬁcation requires a different approach from
stablished calciﬁed plaque because CT does not have suﬃcient
esolution to visualise the tiny calcium-containing crystals de-
osited within the arterial wall. 18 F-Sodium ﬂuoride ( 18 F-ﬂuoride
r 18 F-NaF) is a promising radiotracer that binds to hydroxyapatite
rystals deposited during microcalciﬁcation [11] . 
In the vascular system, 18 F-NaF binds to microcalciﬁcation with
reat aﬃnity [33] . This is true in nearly all metabolic processes
hat lead to vessel calciﬁcation, including atherosclerosis and me-
ial degeneration [33] . The Sodium Fluoride in Abdominal Aor-
ic Aneurysm (SoFIA 3 ) study explored the role of 18 F-NaF in 72
atients with abdominal aortic aneurysms [34] . It showed that
neurysmal aorta exhibit markedly increased 18 F-NaF uptake com-
ared to non-diseased segments. Comparisons of 18 F-NaF bind-
ng between dilated and normal calibre aortae revealed increased
racer uptake in aneurysmal segments (log2 radiotracer uptake
.647 ±0.537 vs. 0.881 ±0.414; difference 0.766; 95% CI: 0.517 to
.011; p < 0.0 0 01) ( Fig. 3 E–F). This binding pattern was indepen-
ent of the aortic calcium score and aortic diameter. Histological
omparisons of aortic tissue obtained following open aneurysm re-
air showed that 18 F-NaF binding correlates with microcalciﬁcation
nd aortic degradation in these subjects. 
Vessel wall calciﬁcation is universal in many aortopathies in-
luding aortic dissections and connective tissue disorders. The role
f 18 F-NaF PET in these diseased states remains of great interest in
ascular imaging. t al., Imaging aortic wall inﬂammation, Trends in Cardiovascular 
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Fig. 5. Association of 18F–sodium ﬂuoride (18F–NaF) uptake with disease pro- 
gression and clinical outcome. ( A ) Rate of aneurysm expansion (millimeters per 
year, log2 transformed) across the tertiles of 18F-NaF uptake. The highest tertile 
expanded more rapidly than those in the lowest tertile (3.10 vs. 1.24 mm/year, re- 
spectively, p = 0.008). Cumulative event rate (censored at date of death) across the 
tertiles of 18F–NaF uptake for ( B ) abdominal aortic aneurysm repair or rupture 
(log-rank p = 0.043) and ( C ) abdominal aortic aneurysm repair (log-rank p = 0.014). 
Adapted from Forsythe RO, Dweck MR, McBride OMB, Vesey AT, Semple SI, Shah ASV, 
et al. 18F–Sodium Fluoride Uptake in Abdominal Aortic Aneurysms: The SoFIA3 Study. 
Journal of the American College of Cardiology. 2018 Feb 6;71(5):513–23. isk stratiﬁcation 
Studying the biology within aortic tissue offers a new perspec-
ive on aortic diseases. Morphological change and established calci-
ed plaque are late manifestations of aortic wall disease. A combi-
ation of anatomical imaging with the pathological processes seen
sing PET offers a more complete assessment of diseased aortic
tate. Together, these modalities promise to improve risk predic-
ion models. 
ortic expansion 
Aortic expansion is sporadic and is accelerated at larger diame-
ers. The aortic wall continues to weaken as the aorta enlarges, po-
entially leading to rupture. However, aortic size alone is unreliable
ecause sub-threshold aneurysms may also rupture. Alternatively,
thers remain intact despite signiﬁcant growth. Clinical practice is
uided by historical data that relies on late features such as diam-
ter change as measured on ultrasound or cross-sectional anatom-
cal imaging [35] . 
The approach of managing aortic aneurysmal disease using a
lanket threshold for intervention is inadequate. For instance, it
oes not account for variations in normal aortic diameter due to
ex and ethnicity. Biological imaging provides insight to the patho-
ogical mechanisms driving aortic expansion. In the SoFIA 3 study
36] , individuals that had the highest uptake of 18 F-NaF in the
ost-diseased aneurysmal segment also had the fastest rate of aor-
ic growth (log 2 
18 F-NaF uptake r = 0.365; p = 0.006) and compos-
te end-point of rupture or repair (log-rank p = 0.043) ( Fig. 5 ) [37] .
his ﬁnding remained true independent of potential confounding
actors such as aortic size and clinical risk factors. The SoFIA 3 study
howed for the ﬁrst time that detecting markers of aortic degener-
tion in aortopathy can predict aortic expansion at a much earlier
imepoint than is currently possible. 
Similarly, resident macrophages in the aortic wall of abdom-
nal aortic aneurysms can be detected using USPIOs on T2 ∗-
eighted MRI. The Magnetic resonance imaging for Abdominal
ortic Aneurysms to predict Rupture or Surgery (MA 3 RS) study
as the ﬁrst to prospectively study resident aortic macrophages
n a large clinical cohort ( n = 342). There were 140 clinical
vents consisting of 126 aneurysm repairs and 17 aortic rup-
ures. Survival analysis showed increased aneurysm repair or rup-
ure (log rank p = 0.028) and a trend towards aneurysm-related
ortality (log rank p = 0.059) when USPIO uptake was high
20] . 
Weakening of the aortic wall is a feature of other aortopathies
oo, such as aortic dissections or aortic manifestations of con-
ective tissue disorders. Aortic expansion is much faster in these
onditions. Again, the only clinically useful predictor of growth is
ortic size. Since the thoracic aorta is most commonly affected,
urveillance requires regular CT or MR imaging to predict aortic
upture. This perhaps explains why the 3-year mortality follow-
ng aortic dissection approaches 1-in-4 [38] . Mortality increases
apidly in connective tissue disorders such as Marfan syndrome.
ere, cardiovascular complications are responsible for up to 90%
f deaths. There is a pressing need to improve our predictions of
ortic expansion and rupture. 
Preliminary data suggest focal uptake of 18 F-NaF within the aor-
ic wall following dissections in both, Marfan- and non-syndromic
ortae ( Fig. 6 ). Indeed, the pathological processes underlying aortic
xpansion in aortopathies share common pathways involving me-
ial degeneration and calcium mineralization. Similar to abdomi-
al aortic aneurysms, 18 F-NaF PET/CT offers the potential to predict
ortic expansion in these aortopathies as well. Please cite this article as: M.B.J. Syed, A.J. Fletcher and M.R. Dweck et al., Imaging aortic wall inﬂammation, Trends in Cardiovascular 
Medicine, https://doi.org/10.1016/j.tcm.2018.12.003 
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Fig. 6. 18 F-Sodium Fluoride following aortic dissection . ( i ) Contrast enhanced computed tomography, ( ii ) 18 F-Sodium Fluoride positron emission tomography and 
( iii ) combined 18 F-Sodium Fluoride positron emission tomography/ computed tomography in a patient with ( A ) hypertension-induced aortic dissection and ( B ) in a pa- 
tient with Marfan Syndrome. 
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i  Occlusive aortic disease 
Atheroma is the most common cause of chronic aortic occlusive
disease. Intervention is driven by clinical symptoms such as but-
tock or lower limb claudication ultimately leading to rest pain and
tissue loss. The strongest predictors of disease progression are clin-
ical risk factors and management is focused on addressing these.
The progression of occlusive aortic disease is highly variable and
predicting disease evolution is challenging. 
18 F-NaF PET detects active plaque biology and better differ-
entiates culprit from non-culprit lesions with greater sensitivity
than 18 F-FDG PET in the coronary and carotid vessels [39] . Plaques
with high 18 F-NaF binding exhibit high-risk features, such as dense
macrophage inﬁltration, larger necrotic cores, thin ﬁbrous caps and
vessel remodelling [40] . Aortic atheroma shares common features
with plaques found in smaller calibre vessels. 18 F-NaF uptake in
the large peripheral vessels is a marker of global calcium burden
and correlates strongly with established cardiovascular risk factors
[41] . The role of aortic 18 F-NaF PET/CT in atheromatous aortic and
peripheral vascular disease remains to be evaluated. 
Future direction 
Current guidelines recommend regular surveillance of aortae at
risk of dilatation. Ultrasound is suﬃcient to measure the diame-
ter of the abdominal aorta but serial CT or MRI is required to im-
age the thoracic aorta. Evidence to recommend routine molecular
or metabolic imaging in aneurysmal aortic disease is lacking al-
though 18 F-FDG PET is increasingly being used for aortitis. Larger
clinical studies are required to examine the true predictive value
of metabolic imaging in aortopathy to predict disease progres-
sion. These investigations are resource intensive and biologicallyPlease cite this article as: M.B.J. Syed, A.J. Fletcher and M.R. Dweck e
Medicine, https://doi.org/10.1016/j.tcm.2018.12.003 ompatible radiotracers need to be manufactured in a timely fash-
on to prevent premature decay. For many radiotracers, this re-
ains a signiﬁcant barrier to translating to clinical practice. 
18 F-NaF PET/CT is more readily manufactured than other trac-
rs, and has shown promising initial data to detect vessel degen-
ration and to predict disease progression. Collaborative effort s to
acilitate larger studies on 18 F-NaF PET are required to validate its
se further in aneurysmal disease, as this is perhaps the most
romising approach to date that could be readily translated into
he clinic. 
onclusion 
Atherosclerosis, aneurysm formation and aortitis represent in-
ependent aortopathies that are all affected by aortic wall inﬂam-
ation. Atherosclerosis involves intimal injury and remodelling,
hereas aneurysm formation results from medial degeneration.
utoimmune aortitis is characterized by both, medial inﬁltration
nd marked intimal hypertrophy. The cellular and molecular pro-
esses leading to these aortic diseases are varied but also share
ommon pathways such as vessel wall calciﬁcation. Here, microcal-
iﬁcation is an early pathological feature that occurs in response to
ellular destruction and signiﬁes intense active disease. 
Detecting early microcalciﬁcation using 18 F-NaF PET/CT holds
reat promise because it identiﬁes necrotic material within vas-
ular beds that drives further inﬂammation. In abdominal aortic
neurysms, 18 F-NaF PET/CT identiﬁes aneurysms that grow rapidly
r require surgical repair. Similarly, in atherosclerotic disease, 18 F-
aF identiﬁes culprit plaques following cap rupture. 
Metabolic imaging and the emergence of novel radiotrac-
rs, such as SST2 and TSPO ligands, means that we can non-
nvasively identify metabolic activity related to inﬂammatoryt al., Imaging aortic wall inﬂammation, Trends in Cardiovascular 
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 rocesses before morphological changes manifest. The combination
f metabolic imaging with established anatomical imaging offers a
ore complete assessment of inﬂammation, improves risk stratiﬁ-
ation and may ultimately guide therapy. 
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